TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07650123: A Multicentre, Double Blind, Placebo Controlled, Clinical Trial to Investigate the Effects and Tolerability of 7-Ketolithocholic Acid, a Novel Food, Associated to Diet and Physical Activity, in Lowering Fasting Plasma Gl

Sponsor: ICE S.p.A. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 100 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,540,400

Rescue Site Savings

+$4,316,000

Unlock Full NCT07650123 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07650123 Rescue Dossier →